BillionaireNet
Baumbach
Johannes von Baumbach
Rank #668
GERMANYHealthcarePharma

Johannes von Baumbach

Net Worth
$5.807B
0% (24h)
Johannes von Baumbach is the world's youngest billionaire, inheriting a substantial fortune from the Boehringer Ingelheim pharmaceutical company. Born in 2006, Johannes's net worth is estimated at $5.7 billion as of December 2025. His wealth stems from his stake in Boehringer Ingelheim, the largest privately-owned pharmaceutical company globally. While maintaining a low public profile, Johannes is known to be a competitive skier. His family is known for its preference for privacy, and it is unknown whether he or his siblings hold any role within the company.

The Full Dossier

Early Life

Johannes von Baumbach was born in 2006 into the wealthy von Baumbach family, who control the pharmaceutical giant Boehringer Ingelheim. The family is known for its discretion, and little is known about Johannes's early life or education. However, he is known to be a competitive skier in Austria. His father, Andreas von Baumbach, is a senior executive within the company, and his grandfather, Hubertus von Baumbach, is the current chairman.

Rise to Success

Johannes's wealth comes from his inheritance of a stake in Boehringer Ingelheim, the world's largest privately owned pharmaceutical company. The company was founded in 1885 by Albert Boehringer and has grown into a global leader in the pharmaceutical industry. The family's wealth has been preserved through generations, with Johannes and his three siblings each holding an estimated $5.7 billion.

Key Business Strategies

Boehringer Ingelheim's success is rooted in its focus on research and development, accounting for nearly 20% of the company's annual revenue. The company's focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life. Its Animal Health division is another global leader in veterinary medicine, dedicated to developing and delivering products that protect and enhance animal well-being.

Philanthropy

The Boehringer and Von Baumbach families are deeply committed to philanthropy. The Boehringer Ingelheim Foundation funds scientific research and education, while other family-led initiatives focus on public health, environmental sustainability, and social welfare.

Wealth Trajectory